• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DIASORIN INC LIAISON SARS-COV-2 TRIMERICS IGG; QUALITATIVE IVD TEST KIT FOR THE DETECTION OF ANTIBODIES TO SARS-COV-2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DIASORIN INC LIAISON SARS-COV-2 TRIMERICS IGG; QUALITATIVE IVD TEST KIT FOR THE DETECTION OF ANTIBODIES TO SARS-COV-2 Back to Search Results
Catalog Number 311510
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/17/2022
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, part number 311510 that has a similar product distributed in the us under eua, part number 311510d.The customer ran four instand survey samples which resulted as follows, (b)(6) (instand 416067) 169 bau/ml, (b)(6) (instand 416068) >2080 bau/ml, (b)(6) (instand 416069) 1500 bau/ml and (b)(6) (instand 416070) 33.7 bau/ml.Sample (b)(6) (instand 416070) was low out of the acceptable instand survey range.Sample (b)(6) (instand 416070) was repeated by the customer in two replicates on (b)(6) 2022 and resulted at 42.1 and 41.8 bau/ml which falls within the acceptable instand survey range.Internal testing performed by diasorin inc.On (b)(6) 2022 with liaison sars-cov-2 trimerics igg (p/n: 311510 lot: 136290), liaison sars-cov-2 trimerics igg control set (p/n: 311511 lot: 136116) and five internal quality control samples was evaluated and no product problem was identified.Liaison sars-cov-2 trimerics igg control 1 range is n.A.To 15.6 bau/ml, control 2 range is 66.5 to 123 bau/ml.Control 1 resulted at <4.81 bau/ml and control 2 resulted at 94.5 bau/ml.Both liaison sars-cov-2 trimerics igg controls and all internal qc samples resulted within the established ranges, including those near the assay cutoff of 33.8 bau/ml.The assay met all specifications and performed as intended.
 
Event Description
In light of the covid-19 pandemic and the subsequent emergency use authorizations (euas) for sars-cov-2 diagnostic tests, per the conditions of authorization for this product, suspect false negatives and false positives will be reported under 21cfr 803, as well as significant changes in expected performance characteristics.There has been no report of patient injury/death due to contribution of alleged false testing results in this event or others with this ivd; however, this is being reported conservatively in the case that if this alleged malfunction were to recur there is a non-remote potential for a patient to incur a serious injury/death.Diasorin inc.Received a customer complaint alleging that they failed an external survey, instand sars-cov-2 ak-rv because the fourth sample of the survey, id number (b)(6), was reported as 33.7 bau/ml = neg.The expected result was equivocal or positive.The customer did not provide any patient information and no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIAISON SARS-COV-2 TRIMERICS IGG
Type of Device
QUALITATIVE IVD TEST KIT FOR THE DETECTION OF ANTIBODIES TO SARS-COV-2
Manufacturer (Section D)
DIASORIN INC
1951 northwestern ave.
stillwater MN 55082 0285
Manufacturer (Section G)
DIASORIN INC
1951 northwestern ave.
stillwater MN 55082 0285
Manufacturer Contact
kym pieper
1951 northwestern ave.
stillwater, MN 55082
6514399710
MDR Report Key16381984
MDR Text Key309611962
Report Number2182595-2022-00005
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
EUA 202996
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/08/2022
Device Catalogue Number311510
Device Lot Number136290
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-